A17349 Abdominal circumference and blood pressure in subjects without personal history of cardiovascular disease or antihypertensive treatment

2018 ◽  
Vol 36 ◽  
pp. e88-e89
Author(s):  
Rafael Hernandez-Hernandez ◽  
José Andrés Octavio ◽  
Lucia Amendola ◽  
Mónica Gúzman ◽  
Antonieta Costantini ◽  
...  
2020 ◽  
Vol 38 (9) ◽  
pp. 1737-1744
Author(s):  
Maria Grazia Radaelli ◽  
Stefano Ciardullo ◽  
Silvia Perra ◽  
Rosa Cannistraci ◽  
Eleonora Bianconi ◽  
...  

2022 ◽  
Vol 28 (1) ◽  
Author(s):  
Linda P. Bolin ◽  
Amelia D. Saul ◽  
Lauren L. Bethune Scroggs ◽  
Carolyn Horne

Abstract Background Cardiovascular disease is one of the leading causes of death globally with hypertension being a primary cause of premature death from this disease process. Individuals with a family history of cardiovascular disease and hypertension are at a greater risk for developing the same sequela. Autonomic cardiac control is important in the level of cardiac function. One intervention that is effective in improving cardiovascular function is heart rate variability biofeedback training. The purpose of our study was to determine the effectiveness of heart rate biofeedback training on HRV and blood pressure in individuals with a family history of cardiovascular disease. Methods Thirty-four participants (76.5% female, 22.7 ± 4.3 years) completed a baseline assessment and training using an established short-term HRV protocol followed by two weeks of at-home paced breathing employing a smartphone application. The participants were then reassessed in a biofeedback clinic. Results The participants physiological measures showed a significant increase in means between pre and post intervention of SDNN (t (32) = 2.177, p =.037) and TP, (t (32) = 2.327 p = .026). Correlation noted a medium effect on diastolic blood pressure and high frequency heart rate variability, F, r = .41, n =33, p < .05. A multiple regression with all predictor variables in the model found no significance with diastolic and systolic blood pressure. Conclusions The findings from this pilot study demonstrated that a two-week paced breathing intervention may assist in reducing heart rate and diastolic blood pressure while improving heart rate variability.


2017 ◽  
Vol 312 (1) ◽  
pp. R49-R54 ◽  
Author(s):  
Sushant M. Ranadive ◽  
Ronee E. Harvey ◽  
Brian D. Lahr ◽  
Virginia M. Miller ◽  
Michael J. Joyner ◽  
...  

Hypertensive pregnancy (HTNP) is a risk factor for future cardiovascular disease. Exaggerated cardiovascular responses to physical stress are also considered an independent marker of cardiovascular disease risk. However, there are limited data regarding the blood pressure (BP) responses to acute stress in women, who have a history of HTNP. Hence, the aim of the study is to compare BP responses to a physical stress in postmenopausal women with a history of HTNP to age- and parity-matched women with a history of normotensive pregnancy (NP). Beat-to-beat BP and heart rate was recorded in 64 postmenopausal women with [age = 58.5 (55.2, 62.2) yr, where values are the median, 25th percentile, and 75th percentile] and without [age = 59.4 (55.9, 62.4) yr] a history of HTNP before and during isometric handgrip (IHG) exercise (30% of maximal voluntary contraction) to fatigue. Muscle metaboreflex was measured during postexercise ischemia following IHG exercise. BP variables increased similarly in response to IHG exercise [systolic: NP = 11.5 (8.9, 17.6) %, HTNP = 11.3 (9.5, 15.9) %; diastolic NP = 11.2 (7.9, 13.3) %, HTNP = 9.5 (7.1, 14.3) %; mean blood pressure: NP = 9.8 (5.0, 13.6) %, and HTNP = 7.2 (4.4, 10.4) %] and postexercise ischemia [systolic: NP = 14.1 (10.3, 23.0) %, HTNP = 15.8 (10.6, 21.4) %; diastolic NP = 12.2 (4.8, 17.0) %, HTNP = 10.4 (5.3, 17.1) %; and mean blood pressure: NP = 11.1 (6.1, 17.9) %, HTNP = 9.4 (2.9, 14.8) %] in both groups. Although having a history of HTNP is associated with future cardiovascular disease risk, results from this study suggest that the risk may not be manifested through altered cardiovascular metaboreflex response to physical stressors.


2008 ◽  
Vol 13 (6) ◽  
pp. 325-332 ◽  
Author(s):  
Robert H. Fagard ◽  
Lutgarde Thijs ◽  
Jan A. Staessen ◽  
Denis L. Clement ◽  
Marc L. De Buyzere ◽  
...  

Jurnal NERS ◽  
2020 ◽  
Vol 14 (3) ◽  
pp. 383
Author(s):  
Wahyu Sukma Samudera ◽  
Gracia Victoria Fernandez ◽  
Rahmatul Fitriyah ◽  
Hidayat Arifin ◽  
Shenda Maulina Wulandari ◽  
...  

Introduction: Fasting is defined as the voluntary abstinence from eating for variable time intervals and it has been associated with potential beneficial impacts on human health. The study was to review the benefits of fasting on cardiovascular health in humans with or without cardiovascular disease.Methods: The databases search was done using the keywords ‘fasting’ and ‘cardiovascular system’ using Scopus, Science Direct and ProQuest, limited to between 2013 and 2019 for publication year. A total of 3.619 articles were obtained and 15 articles involving experimental and non-experimental studies were used as the reference material.Results: The findings showed that in people who are healthy, fasting can reduce the inflammatory markers (IL-1 & IL-6, TNF-α), the oxidative stress marker (Malondialdehyde), body weight, abdominal circumference, fasting blood glucose, LDL, triglyceride and blood pressure. In people at risk or with cardiovascular disease, fasting can reduce body weight, body mass index, abdominal circumference, fat percentage, blood pressure, triglyceride, the biomarker of inflammation (serum amyloid A), the biomarker of oxidative stress (protein carbonyl), the biomarker of endothelial dysfunction (asymmetric dimethylarginine) and increase the vascular endothelial growth factor.Conclusion: Based on these findings, fasting can improve the health condition of people at risk or with cardiovascular disease by improving the risk factors such as blood pressure, overweight and endothelial dysfunction. In people who are healthy, fasting can be used for the prevention of cardiovascular disease by helping to maintain their weight, blood pressure, LDL and triglyceride within the normal limits.


Author(s):  
Joan Bayó ◽  
Antoni Dalfó ◽  
Maria A Barceló ◽  
Marc Saez ◽  
Carme Roca ◽  
...  

Abstract BACKGROUND The optimal schedule for self-monitoring home BP (SMHBP) readings is enormously important in the diagnosis of different phenotypes related to hypertension. The aim of this study was to determine the prognostic capacity of a three-day SMHBP schedule when using or suppressing the first-day measurements in compiling the results. METHODS A total of 767 newly diagnosed, non-treated patients with no history of cardiovascular disease (CVD) were followed for 6.2 years. As a baseline, office BP measurements were taken for all the patients who then went on to follow a three-day SMHBP schedule, taking two readings in the morning and two in the evening. The prognostic calculation was performed with CVD variables. The prognostic capacity of the three-day schedule was evaluated with and without the first-day readings (12 and 8 readings). RESULTS A total of 223 normotensive subjects (NT), 271 subjects with sustained hypertension (SHT) and 184 white-coat hypertensive subjects (WCH) were followed. The distribution of 98 (14.4%) non-fatal CV events during the follow-up was as follows: WCH 21 (11.4%), NT 9 (4.0%) and SHT 68 (25.1%). No statistically significant differences were observed in the risk of CV events (OR) for the two groups of hypertensives, irrespective of the schedule of readings used (SHT with vs without first-day readings: 8.81 (4.28-18.15) vs 8.61 (4.15-17.85) and WCH with vs without first-day readings: 2.71(1.13-6.47) vs 3.40 (1.49-7.78)). CONCLUSIONS Our findings show that first-day readings do not need to be discarded in order to calculate the final value of an SMHBP schedule.


Circulation ◽  
2017 ◽  
Vol 135 (suppl_1) ◽  
Author(s):  
Marie-Caroline Laï ◽  
Pierre Boutouyrie ◽  
Muriel Tafflet ◽  
Frédérique Tomas ◽  
Catherine Guibout ◽  
...  

Background: Dysautonomy has been suggested to be a mechanism contributing to the well-established association between high depressive symptoms (HDS) and cardiovascular disease (CVD). So far however, at the population level, this question has been addressed using parameters of complex interpretation that are rarely used in the clinical setting. The aim of this study was to quantify the respective association of HDS and antidepressants (ATD) on different heart rate parameters of simple investigation. Methods: The Paris Prospective Study III included subjects recruited in a large health preventive centre in Paris (France) between 2008 and 2012. Four heart rate parameters were measured including resting heart rate (RHR), heart rate immediately after moderate effort (EHR), differences between EHR and RHR, and RR interval. A total score ≥ 7 on a 13-item standardized questionnaire defined the presence of HDS. Information on classes of ATD was obtained on a face-to-face interview with a medical doctor. The association between HDS or ATD and each of the 4 heart rate parameters were quantified in separate linear regression analysis adjusted for age, sex, body mass index, physical activity, personal history of CVD, smoking, diabetes, high blood pressure and beta blockers. To minimize indication bias, the analysis on ATD was adjusted for the propensity score of receiving ATD. Results: The mean age of the 8430 participants was 59.6 years and 39% were women. HDS were noted in 473 subjects and 383 participants were on ATD: 58 on Tricyclics, 232 on Serotonin Specific Reuptake Inhibitor (SSRI) and 80 on Serotonin Norepinephrine Reuptake Inhibitors (NSRI) respectively. Beta-blockers were used by 4.2% of the participants and only 2.1% had a personal history of cardiovascular disease. HDS were associated with slightly higher RHR (+0.9 beats per minute (bpm), p<0.05) and lower RR interval (-21.1 ms, p<0.05). ATD of any class were related to lower RR interval (-22.3 ms, p=0.007), higher EHR (+1.7 bpm, p=0.02) and higher difference between EHR and RHR (+1.5 bpm, p=0.009). While tricyclics and NSRI were both associated with significantly higher RHR (+7.0 and +2.64 bpm respectively, p<0.05), higher EHR (+6.79 and +6.94 bpm respectively, p<0.001), higher difference between EHR and RHR (+2.74, p=0.06 and +5.70, p<0.001 respectively) and lower RR interval (-98.50 ms and -50.63 ms respectively, p<0.001), SSRI was related to lower RHR (-1.81 bpm, p<0.05) and almost significantly higher RR interval (+18.61 ms, p=0.08). Neither sex nor beta-blockers modified these associations. Consistent findings were observed when other propensity score methods were used. Conclusions: Our study suggests that ATD more than HDS are associated with dysautonomy as evaluated by simple and routinely used heart rate parameters.


Author(s):  
Neethu Varghese ◽  
John Shine

Background: Cardiovascular disease (CVD) is the leading cause of death in women and primary target for prevention. Obesity is an important biological risk factor for cardiovascular disease (CVD). The main aim of this study was to answer the question regarding knowledge about preventive measures of CVD. A further aim was to replicate previous findings that obese individuals are at higher risk of developing other biological risk factors for CVD. Objectives of the study: To identify the knowledge level of obese women regarding prevention of cardiovascular disease in a selected community at Mangalore. Method: A descriptive study was conducted among 50 obese women who were selected by Purposive sampling technique. The study was conducted in local areas, at Mangalore. Data was collected through baseline information, structured knowledge questionnaire. The data collected was analysed and interpreted based on descriptive and inferential statistics. Result: Majority of the samples belonged in the age group of 40-45 years (40%), most of their BMI were in obese category (64%), nearly half of the subjects completed pre university education (40%), 64% of the subjects were office workers and have not attained menopause, almost half of them had 2 pregnancies (48%) and majority of them did not undergo hormone replacement therapy (80%), family history of CVD and obesity were 72% and 56% respectively, majority of people had personal history of diabetes mellitus (36%). With regard to level of knowledge, among 50 obese women 50% had average knowledge, 34% had good knowledge, 6% had very good knowledge and 10% had poor knowledge about prevention of cardiovascular diseases. There was a significant association for age, type of occupation, number of pregnancies, hormone replacement therapy and personal history of CVD with knowledge of obese women and no association found for BMI, menopause, family history of CVD and obesity. Conclusion: Knowledge level of obese women regarding prevention of cardiovascular diseases is comparatively low. Various multisectoral approaches are required to improve their knowledge which would help to improve their quality of life.


Sign in / Sign up

Export Citation Format

Share Document